Literature DB >> 3558454

Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents.

V Göbel, H Jürgens, G Etspüler, H Kemperdick, R M Jungblut, U Stienen, U Göbel.   

Abstract

A total of 60 consecutive patients with localized Ewing's sarcoma of bone who were entered into the Cooperative Ewing's Sarcoma Study of the German Society of Pediatric Oncology from January 1981 until April 1985 were evaluable for tumor volume at diagnosis. The tumor volume was calculated from plain X-rays and CT scans as ellipsoidal or cylindrical depending on the tumor configuration and presence or absence of a soft tissue component. The 3-year disease-free survival rate according to Kaplan-Meier life table analysis was 78% for tumors with a volume less than 100 ml compared to 17% for tumors greater than or equal to 100 ml volume. These results were independent of the site of the tumor, though larger tumors were primarily located in central and proximal extremity sites. Maximal tumor extension was less precise than tumor volume in predicting prognosis. The ratio of tumor volume to body surface area, body length, or body weight did not increase the ability to separate prognostic groups compared to tumor volume. The better prognosis for patients following radical surgery seems to be in part due to a biased distribution of tumor volumes within local therapy groups, since more patients with smaller tumors had surgery for local control.

Entities:  

Mesh:

Year:  1987        PMID: 3558454     DOI: 10.1007/BF00391442

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  12 in total

1.  Combined modality therapy of Ewing's sarcoma.

Authors:  T C Pomeroy; R E Johnson
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

2.  [The CESS 81 cooperative Ewing sarcoma study of the Society for Pediatric Oncology: an interim report].

Authors:  H Jürgens; M Cserhati; U Göbel; P Gutjahr; A Jobke; P Kaatsch; J Kühl; J Sekera; K Winkler
Journal:  Klin Padiatr       Date:  1983 May-Jun       Impact factor: 1.349

3.  Influence of prognostic factors on survival in Ewing's sarcoma.

Authors:  D L Glaubiger; R W Makuch; J Schwarz
Journal:  Natl Cancer Inst Monogr       Date:  1981-04

4.  Local treatment of Ewing's sarcoma: radiation therapy versus surgery.

Authors:  T J Kinsella; A S Lichter; J Miser; L Gerber; E Glatstein
Journal:  Cancer Treat Rep       Date:  1984-05

5.  The prognostic significance of soft tissue extension in Ewing's sarcoma.

Authors:  C M Mendenhall; R B Marcus; W F Enneking; D S Springfield; T L Thar; R R Million
Journal:  Cancer       Date:  1983-03-01       Impact factor: 6.860

6.  [Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol].

Authors:  F Deméocq; P Carton; C Patte; O Oberlin; D Sarrazin; J Lemerle
Journal:  Presse Med       Date:  1984-03-24       Impact factor: 1.228

7.  Intensive systemic chemotherapy in localized Ewing's sarcoma in childhood. A historical trial.

Authors:  J M Zucker; M Henry-Amar; D Sarrazin; R Blache; C Patte; O Schweisguth
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

8.  Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study.

Authors:  M E Nesbit; C A Perez; M Tefft; E O Burgert; T J Vietti; J Kissane; D J Pritchard; E A Gehan
Journal:  Natl Cancer Inst Monogr       Date:  1981-04

9.  Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study.

Authors:  C A Perez; M Tefft; M E Nesbit; E O Burgert; T J Vietti; J Kissane; D J Pritchard; E A Gehan
Journal:  Natl Cancer Inst Monogr       Date:  1981-04

10.  Ewing's sarcoma: ten-year experience with adjuvant chemotherapy.

Authors:  G Rosen; B Caparros; A Nirenberg; R C Marcove; A G Huvos; C Kosloff; J Lane; M L Murphy
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

View more
  36 in total

1.  Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma.

Authors:  Chang-Bae Kong; Won Seok Song; Wan Hyeong Cho; Jung Moon Oh; Dae-Geun Jeon
Journal:  Clin Orthop Relat Res       Date:  2011-10-19       Impact factor: 4.176

2.  (Sub)periosteal Ewing's sarcoma of bone.

Authors:  P Wuisman; A Roessner; S Blasius; R Erlemann; W Winkelmann; J Ritter
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Ewing's sarcoma and primitive neuroectodermal tumor of hand and forearm. Experience of the Cooperative Ewing's Sarcoma Study Group.

Authors:  Wolfgang Daecke; Susanne Ahrens; Herbert Juergens; Abdul-Kader Martini; Volker Ewerbeck; Rainer Kotz; Winfried Winkelmann; Ludger Bernd
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-22       Impact factor: 4.553

4.  Evaluation of volume and solitary bone cyst remodeling using conventional radiological examination.

Authors:  Maciej Glowacki; Anna Ignys-O'Byrne; Iwona Ignys; Przemyslaw Mankowski; Piotr Melzer
Journal:  Skeletal Radiol       Date:  2009-05-14       Impact factor: 2.199

5.  The accurate surgical margin before surgery for malignant musculoskeletal tumors: a retrospective study.

Authors:  Yun Hao; Caihong Yang; Jinpeng He
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

6.  The impact of intraoperative brachytherapy on surgery of Ewing's sarcoma.

Authors:  T Ozaki; A Hillmann; C Rübe; R Rödl; M Hein; C Hoffmann; S Blasius; H Jürgens; W Winkelmann
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

7.  Digital holographic microscopy for longitudinal volumetric imaging of growth and treatment response in three-dimensional tumor models.

Authors:  Yuyu Li; Ljubica Petrovic; Jeffrey La; Jonathan P Celli; Chandra S Yelleswarapu
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

8.  Ewing's sarcoma of the pelvis.

Authors:  R Capanna; A Toni; A Sudanese; D McDonald; G Bacci; M Campanacci
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

9.  Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.

Authors:  Dae-Geun Jeon; Won Seok Song; Wan Hyeong Cho; Chang-Bae Kong; Sang Hyun Cho
Journal:  Clin Orthop Relat Res       Date:  2014-02-27       Impact factor: 4.176

10.  Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institution.

Authors:  Gaetano Bacci; Stefano Boriani; Alba Balladelli; Enza Barbieri; Alessandra Longhi; Marco Alberghini; Katia Scotlandi; Cristiana Forni; Paola Pollastri; Daniel Vanel; Mario Mercuri
Journal:  Eur Spine J       Date:  2009-03-11       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.